Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Otsuka joins forces with IBM for Watson-based digital venture

Otsuka joins forces with IBM for Watson-based digital venture Otsuka Digital Health will develop software to analyse psychiatric patient data

FDA knocks-back Otsuka's digital pill plans

FDA knocks-back Otsuka's digital pill plans Wants more data on its combination of Abilify and Proteus sensor and pill. ... Otsuka's plans to combine its antipsychotic drug Abilify with Proteus' digital pill to measure adherence have suffered a setback in the US after the FDA declined to approve

BMS claims 80% market share for Opdivo in US

BMS claims 80% market share for Opdivo in US Opdivo and Eliquis helped BMS offset a sizeable loss in sales for former blockbuster schizophrenia drug Abilify (aripiprazole) - which slumped to $33m from $554m a year ago - and the loss of

FDA approves Alkermes’ long-acting Abilify

FDA approves Alkermes’ long-acting Abilify Aristada given the nod as injectable antipsychotic. Alkermes' Aristada (aripiprazole lauroxil) has been approved by the FDA as a long-acting injectable version of Abilify. ... The approval of Aristada will come as further bad news to Otsuka as Abilify

CHMP recommends 19 new medicines for European approval

CHMP recommends 19 new medicines for European approval Generic Approvals. Additionally five generic medicines were recommended by the CHMP, including Aripiprazole Accord (aripiprazole) - a version of Lundbeck's schizophrenia and bipolar disorder treatment Abilify.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics